About this episode

Wing-Lok Chan MBBS discusses the benefits of the SUPPORT+ mobile app for patients with advanced cancer.

An interview with: Wing-Lok Chan MBBS, Clinical Associate Professor, Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China CHICAGO, USA—Patients with advanced cancer had their quality of life preserved and required fewer hospitalizations when they monitored themselves digitally by using the SUPPORT+ mobile phone app prompting better self-management while giving regular access to guidance from a nurse. This was in a randomized controlled study reported to the 2026 Annual Meeting of the American Society of Clinical Oncology by Wing-Lok Chan MBBS, from the Department of Clinical Oncology at the University of Hong Kong, in China. She talked about the findings with Peter Goodwin:

People in this episode

Host: Peter Goodwin

Guest: Wing-Lok Chan MBBS

Topics covered

• advanced cancer
• mobile health
• patient quality of life
• nurse supervision
• self-management
• randomized controlled study

Keywords

• SUPPORT+ app
• advanced cancer
• quality of life
• hospitalizations
• nurse guidance
• self-management
• randomized controlled study

Mentioned in this episode

Organizations: Department of Clinical Oncology, The University of Hong Kong

Places: Hong Kong, USA

More episodes of Audio Journal of Oncology Podcast

• Kevin Kalinsky MD; ASCO 2026: ASCENT-04 Study Finds Sacituzumab Govitecan plus Pembrolizumab Helps Patients with Previously Untreated Metastatic PD-L1 Positive Triple Negative Breast Cancer Live Longer Without Progression Beyond Subsequent Therapies · July 14, 2026 · 8 min
• Ghassan K. Abou-Alfa MD PhD; ASCO 2026: Adding Doublet Immune Checkpoint Inhibition to Embolization with or without anti-Growth Factor TKI Therapy Extends Progression Free Survival in Patients with Hepatocellular Cancer · June 30, 2026 · 9 min
• Jonathan W. Goldman MD and David R Spigel MD; ASCO 2026: Patients with RET Fusion Positive Early Stage Non-Small Cell Lung Cancer Benefit from Selpercatinib: LIBRETTO-432 Early Results · June 23, 2026 · 10 min
• Mark A Dickson, ASCO 2026: Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with Advanced Dedifferentiated Liposarcoma · June 15, 2026 · 7 min
• Jana de Boniface MD PhD; ASCO 2026: Omitting Axillary Lymph Node Dissection is Safe for Patients with Breast Cancer Macrometastases to One or Two Sentinel Lymph Nodes · June 11, 2026 · 7 min
• Jean-Marc Classe, MD PhD; ASCO 2026: Timing of Surgery for Advanced Ovarian Cancer among Neoadjuvant and Adjuvant Chemotherapy Cycles: Early Findings from Randomized CHRONO Trial · June 9, 2026 · 9 min

Explore listener stats, chart rankings, contacts and more on the Audio Journal of Oncology Podcast podcast page.